Activin signaling as an emerging target for therapeutic interventions - Wikidata - wikimedia - TriplyDB

Activin signaling as an emerging target for therapeutic interventions

Activin signaling as an emerging target for therapeutic interventions

http://www.wikidata.org/entity/Q37268461

about

Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting Canonical Notch signaling plays an instructive role in auditory supporting cell development.Swertisin an Anti-Diabetic Compound Facilitate Islet Neogenesis from Pancreatic Stem/Progenitor Cells via p-38 MAP Kinase-SMAD Pathway: An In-Vitro and In-Vivo Study Beyond differential expression: the quest for causal mutations and effector molecules Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function.Therapies for musculoskeletal disease: can we treat two birds with one stone?Emodin prevents hypoxic-ischemic neuronal injury: Involvement of the activin A pathway.Prostate stem cell antigen: a Jekyll and Hyde molecule?Immunohistochemical labeling of the inhibin/activin betaC subunit in normal human placental tissue and chorionic carcinoma cell lines Involvement of the serum response factor coactivator megakaryoblastic leukemia (MKL) in the activin-regulated dendritic complexity of rat cortical neurons AAV2/8-hSMAD3 gene delivery attenuates aortic atherogenesis, enhances Th2 response without fibrosis, in LDLR-KO mice on high cholesterol diet.Evidence of inhibin/activin subunit betaC and betaE synthesis in normal human endometrial tissue.Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's disease Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β Short-term energy deprivation alters activin a and follistatin but not inhibin B levels of lean healthy women in a leptin-independent manner.Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure Activin A programs the differentiation of human TFH cells.Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.The immunoregulatory and fibrotic roles of activin A in allergic asthma Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies.Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells.Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments.Transgenic GATA-4 expression induces adrenocortical tumorigenesis in C57Bl/6 mice.Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact Modulators of erythropoiesis: emerging therapies for hemoglobinopathies and disorders of red cell production.Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.Activin A and bone metastasis.Role of activin in bacterial infections: a potential target for immunointervention?Antagonism of activin by activin chimeras.The role of activin in mammary gland development and oncogenesis.Activins in adipogenesis and obesity.Muscle-bone interactions: basic and clinical aspects.Integrated therapies for osteoporosis and sarcopenia: from signaling pathways to clinical trials.Physical activity and its mechanistic effects on prostate cancer.TGF-β Family Signaling in Connective Tissue and Skeletal Diseases.The inhibin-βC subunit is down-regulated, while inhibin-βE is up-regulated by interferon-β1a in Ishikawa carcinoma cell line.Follistatin is induced by IL-1β and TNF-α in stromal cells from endometrioma.Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line.Prognostic value of follistatin-like 3 in human invasive breast cancer Increased Expression of Follistatin in Breast Cancer Reduces Invasiveness and Clinically Correlates with Better Survival.

P2860

Q24609841-63306C7F-6977-4BD9-81FD-D4BD6F5D6B68 Q27301382-AD97D186-A87E-47B7-A3C5-7A35E2E795CF Q27305573-A8DAD6D0-309B-4458-8E4E-1FEE87A0448C Q28727736-E7B7A3E5-CFEE-40C8-9FE6-A55BA03276D3 Q33569061-F817DA23-CBE5-4FBD-948F-5046BF5EA818 Q33851441-55D40319-F7E7-4D90-A528-5719DDD6666B Q33937600-1D1C14C3-717F-4370-8A6D-2675BC19C258 Q34001130-232961BA-140F-4C92-A23B-306EBD1A6251 Q34008312-9A1F6B0B-0DCC-4DFD-AC1D-33E728575D55 Q34236843-3D43EAF2-2CAD-4E95-9015-24710D5645B5 Q34306694-3F57FB80-BC4E-4FDF-92A0-F11F8DE24FD2 Q34408341-8E236B69-0A65-4058-9248-D7A98BA4848B Q34648643-3285B6A1-63B7-4A9C-AF95-237F078884A0 Q35566076-14111F9E-6443-4185-93AA-B90A6C95B5B2 Q35597909-F49805E4-EA79-4531-BC70-6CECACD90560 Q36003155-CC24BBEF-0B93-4C69-A449-A98BF3DCC34A Q36067435-C9F32D54-4B0C-4F58-926F-53A94B3F37C0 Q36254527-CADFD283-684E-4CEC-B3EE-A00D959CA4BC Q36393944-BF89B8EE-7CE1-4D74-8CA3-AAB47C94FF32 Q36428144-179BC8C2-0B5C-44DA-87DA-9A6489651F46 Q36451785-75F7A834-D350-4FBE-A951-A87534749A94 Q36805205-0D502344-908C-4C3F-9654-AC6CCA56E55F Q36918299-B0CC5300-6347-4B1D-8BA3-9A2ADF8AAD1D Q37348262-FE26EDD2-1E79-41AE-8A1A-2C3B96CD1034 Q37673351-E10E5F17-9178-4566-AF04-631A70BC29E9 Q37687616-B4F6938C-60C7-4EB3-8DF3-FFF1769D2718 Q37763650-4BB51DD5-23EF-46A2-B9F7-7230C5AF92D7 Q37793227-768F2508-E5E5-4106-A4F0-73BFCD25A2A5 Q37847427-27600FDF-C56A-4499-B1E4-332452009074 Q37863042-69364D3B-397C-45E9-B04F-9595C47B2CF8 Q37988764-8FB8C4C8-324D-4437-8EF5-BB521A8AC826 Q38132696-3DBB2988-5C8D-45DC-AFD5-FF8A0AC676C8 Q38336740-C3B5EEB8-D743-4EFC-A105-AA939F87DCA4 Q38387928-EB6904EB-8D31-4146-B0A8-B12DCF07BB6C Q39155183-E2A96614-6438-43EA-BAEA-EC843420EDA0 Q39167627-027B67B5-57A4-490B-BCB0-8180985D5080 Q39241103-04F00C07-DCFE-40ED-A0C6-AFAAB4062885 Q39630960-41EA3AD3-B770-47CE-A11B-2E6E362A948C Q41091935-CBFFD7CA-D702-409E-9E11-A83C9461640F Q41525852-68AF23F8-8B64-4903-949A-1C7064EC0733

P2860

Activin signaling as an emerging target for therapeutic interventions

http://www.wikidata.org/entity/Q37268461

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Activin signaling as an emerging target for therapeutic interventions

@en

Activin signaling as an emerging target for therapeutic interventions.

@nl

type

label

Activin signaling as an emerging target for therapeutic interventions

@en

Activin signaling as an emerging target for therapeutic interventions.

@nl

prefLabel

Activin signaling as an emerging target for therapeutic interventions

@en

Activin signaling as an emerging target for therapeutic interventions.

@nl

P1433

Q37268461-9EF4FF7C-23AB-435E-98CF-468AE51378EB

P1476

Q37268461-D7E5DDB6-AF65-4C9A-8D2F-7EC3AF306EA4

P2093

Q37268461-64B5F7D5-6362-4704-B1E5-FA0CF1586E73

Q37268461-813943B6-8D0B-4820-A383-FCDC9D07BB26

Q37268461-8AB3FEFE-BAB9-4B0F-BFA5-8F3213B5C068

P2860

Q37268461-0044C061-EBC7-4163-B756-AC644E10F95F

Q37268461-01D6ADC7-9A49-4FE1-902E-B0430BA99584

Q37268461-052AD64C-EE3A-4AC2-9F75-DF884BFFF1E3

Q37268461-06EC9316-2450-493C-94E1-F031A3CEEFDC

Q37268461-078AE4C0-E365-4670-A2CC-D3A403F0BF5A

Q37268461-0E6C2B9D-34CA-443B-8F5D-903C82F618CC

Q37268461-0F0EFC03-BBAE-4101-A265-849416D24BD1

Q37268461-0F1129E9-41DE-485E-AF8F-C3946C722006

Q37268461-12D140CD-0520-4430-9B9A-F492B2DF8C28

Q37268461-13794D67-8314-4BDA-8B74-C4CAA3AA67D7

P2888

Q37268461-5516786F-8B79-4197-A95C-7796C0708909

P304

Q37268461-A25304FA-BE06-4C18-A734-B018CAF99F70

P31

Q37268461-077D31B0-47A6-4210-9062-F465864C3482

P356

Q37268461-3C0D270A-2DA9-4F6C-9FD7-453209894E8A

P478

Q37268461-39BEB087-B1EA-4FB8-8DED-5891C25BFF1D

P50

Q37268461-0B92DFF0-22D6-4E93-AE38-859171D83FAF

Q37268461-3777B85A-E22E-45B3-A612-476494CC5576

Q37268461-989F3059-F976-4F77-B6FF-86262CC74F35

Q37268461-FB8C0964-A67C-462E-9F52-32DA34EE1F36

P577

Q37268461-7EC70423-2789-4D50-85F6-7778FC6FA82C

P6179

Q37268461-A538465C-EFB5-412A-B37A-B8DA743C830B

P698

Q37268461-2B72E897-374F-45AF-94A8-A6068D396E69

P932

Q37268461-4C13EC6A-0A3A-46FE-9A85-55F139A26354

P356

P1433

Cell Communication and Signaling

P1476

Activin signaling as an emerging target for therapeutic interventions

@en

P2093

Hiroshi Ageta

http://www.w3.org/2001/XMLSchema#string

Masashi Nakatani

http://www.w3.org/2001/XMLSchema#string

Yoshihide Sunada

http://www.w3.org/2001/XMLSchema#string

P2860

A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs

SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor

Structural basis of Smad2 recognition by the Smad anchor for receptor activation

Identification and characterization of a PDZ protein that interacts with activin type II receptors

Myostatin mutation associated with gross muscle hypertrophy in a child

Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells

Structural basis for the inhibition of activin signalling by follistatin.

Pin1 down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of Smad proteins

Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo

Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3

P2888

P304

15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1478-811X-7-15

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Keisuke Hitachi

Akiyoshi Uezumi

Kunihiro Tsuchida

P577

2009-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010192287

http://www.w3.org/2001/XMLSchema#string

P698

19538713

http://www.w3.org/2001/XMLSchema#string

P932

2713245

http://www.w3.org/2001/XMLSchema#string